Amalgamated Research
Private Company
Funding information not available
Overview
Amalgamated Research LLC (ARi) is a private, established player in industrial process technology, focusing on separation and fluid handling. Its proprietary, patented fractal distribution and mixing technology serves as a functional alternative to turbulence, offering clients significant improvements in efficiency and energy use. The company operates a full-service model, from lab-scale testing and pilot programs to full-scale industrial installation, serving global markets in food, sweeteners, renewables, biofuels, and mining. ARi is a revenue-generating engineering and services firm, not a therapeutic biotech, with its 'pipeline' consisting of new industrial applications for its core platform.
Technology Platform
Patented fractal fluid control technology for high-efficiency industrial distribution, mixing, and separation. This platform underpins their chromatography and ion exchange systems, offering reduced energy use and improved scale-up accuracy compared to conventional turbulent methods.
Opportunities
Risk Factors
Competitive Landscape
ARi competes with other specialized engineering firms and large industrial equipment providers that offer chromatography and ion exchange systems (e.g., Pall, GE Healthcare Life Sciences [now Cytiva] in bioprocessing, and other SMB chromatography providers). Its key differentiator is its patented fractal technology, which claims superior efficiency and energy savings, creating a niche in process-intensification and sustainable design.